China Medical Insurance Bureau: why should we carry out the negotiation on the access of medical insurance drug catalogue?

China Medical Insurance Bureau: why should we carry out the negotiation on the access of medical insurance drug catalogue?

China Medical Security Bureau

Recently, “70 thousand needles of sky high price drugs into medical insurance” boarded the hot search and became the focus of attention from all walks of life. In order to make everyone have a more comprehensive and objective understanding and understanding of the adjustment of the medical insurance drug catalogue, the relevant responsible comrades of the medical administration department of the national medical insurance administration deeply interpreted the work arrangement and relevant considerations of the 2021 national medical insurance drug catalogue access negotiation (hereinafter referred to as the drug negotiation).

Why should we carry out negotiations on the entry of medical insurance drug catalogue?

Medical Security

Drug negotiation refers to the negotiation between the medical insurance department and the pharmaceutical enterprise on the drug payment standard (the payment standard of exclusive drugs is generally equal to its price). The negotiation results directly determine whether the drug is included and at what price in the national medical insurance drug catalogue. According to Article 12 of the Interim Measures for the administration of drugs in basic medical insurance issued by the State Medical Insurance Bureau, the payment standard for exclusive drugs shall be determined through access negotiation.

The main purpose of drug negotiation is to give full play to the role of strategic purchase of medical insurance department, negotiate and negotiate with enterprises on the basis of “national medical insurance use” for drugs included in the negotiation scope, comprehensively achieve the goal of improving fund use efficiency and reducing patient burden, and give full play to the maximum guarantee efficiency with limited medical insurance funds. At the same time, through the value purchase and strategic purchase of medical insurance fund, guide the pharmaceutical industry to take the path of innovative development.

China’s health care negotiations have further reduced the cost of people’s medical treatment and played a great role in improving people’s healthy living standards. Relevant government departments will further strengthen the negotiation of Medicare drugs and further reduce the cost of drugs.

相关文章

Leave a Reply

Your email address will not be published. Required fields are marked *